NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 15 min ago

Alzheimer's-related Resource Centers for Minority Aging Research (AD-RCMAR) (P30)

Tue, 2017-04-04 11:01
Funding Opportunity RFA-AG-18-002 from the NIH Guide for Grants and Contracts. The National Institute on Aging (NIA) invites applications from qualified institutions for the creation of Resource Centers for Minority Aging Research (RCMARs) with a focus on behavioral or social science research related to Alzheimers disease and related dementias (ADRD). The primary purpose of this FOA is (1) to support centers that will enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in ADRD-relevant research in a selected area of scientific focus, and (2) to develop infrastructure to promote advances in this area and increase the number of researchers focused on the health and well-being of minority elders. RCMARs focus on priority areas of social, behavioral, and economic research on the processes of aging at the individual or societal level. The program supports research at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational, with the goal to improve the health, well-being, function, and independence of older Americans. This new cycle of RCMARs will expand the scientific scope of the program to include a subset of centers focused on priority areas of social and behavioral science related to Alzheimers disease, including research on the epidemiology of ADRD, preventive interventions for ADRD, and the formal and informal care challenges of individuals with ADRD and their family members. Consistent with the longstanding focus of the RCMAR program on minority aging research, all centers are also expected to offer mentoring in health disparities and minority aging issues as a major component of their research education programs, thereby enhancing the potential impact of research supported by the program on all sectors of our aging society.

Notice of Change to the Eligible Activity Codes for PA-17-164 "Aging Biology Research to Address Health Disparities (Admin Supp)"

Tue, 2017-04-04 10:46
Notice NOT-AG-17-006 from the NIH Guide for Grants and Contracts

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30)

Tue, 2017-04-04 03:27
Funding Opportunity PAR-17-249 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)

Mon, 2017-04-03 13:50
Funding Opportunity PA-17-247 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U18 cooperative agreement applications to stimulate innovative and collaborative research by utilizing new health information technology (IT) strategies for collecting and using patient-reported outcome (PRO) measures in primary care and other ambulatory care settings.

Centers of Excellence for Training in Glycosciences (K12)

Mon, 2017-04-03 13:39
Funding Opportunity RFA-HL-18-013 from the NIH Guide for Grants and Contracts. The objective of this research career program is to create a national Consortium that focuses on career development of the next generation of biomedical investigators in glycosciences. The ultimate goal of the Consortium is to transform and democratize glycosciences from a super-specialized research domain into the mainstream of biology and clinical translation such that glycans become an integral component of future scholars'/investigators' scientific thinking, thus creating a pathway for major scientific breakthroughs specifically in heart, lung, blood and sleep (HLBS) sciences.

Notice of Expiration of PA-16-373, Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)

Mon, 2017-04-03 13:11
Notice NOT-AI-17-022 from the NIH Guide for Grants and Contracts

Notice of Expiration of PA-16-372 "Small Grants on Primary Immunodeficiency Diseases (R03)"

Mon, 2017-04-03 13:03
Notice NOT-AI-17-021 from the NIH Guide for Grants and Contracts

Change to NIH Method of Payment for Awards to Federal Institutions and Individual Fellowships at Federal Sponsoring Institutions

Mon, 2017-04-03 12:52
Notice NOT-OD-17-052 from the NIH Guide for Grants and Contracts

NIAAA Policy for Submission of Applications Containing Genome-Wide Association Studies

Mon, 2017-04-03 12:46
Notice NOT-AA-17-002 from the NIH Guide for Grants and Contracts

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)

Mon, 2017-04-03 11:30
Funding Opportunity PAR-17-245 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.

Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21)

Mon, 2017-04-03 03:29
Funding Opportunity PA-17-246 from the NIH Guide for Grants and Contracts. This FOA issued by AHRQ invites grant applications for funding to conduct exploratory and developmental research grants (R21) for projects in the early and conceptual stages of development that will contribute to the evidence base of how health information technology (IT) improves health care quality and outcomes.

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)

Mon, 2017-04-03 02:12
Funding Opportunity PA-17-248 from the NIH Guide for Grants and Contracts. The overarching goal of this Funding Opportunity Announcement (FOA) is to support collaborative pilot projects to generate new ideas and approaches to reduce the incidence and/or severity of auto-inflammatory or autoimmune adverse events in the setting of cancer immunotherapy. In order to facilitate formation of multidisciplinary teams with expertise in mechanisms of cancer immunology/immunotherapy as well as immune tolerance and/or autoimmunity, teams that include (a) a current NCI grantee and a current NIAID grantee, or (b) a current NCI grantee and a current NIAMS grantee, are encouraged to propose collaborative pilot projects that utilize their complementary and synergistic expertise.

Pages